Drug or treatment
Ianalumab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Ianalumab that are recruiting, at sites in 36 countries (most in United States (4), Brazil (3), China (3)). By phase: Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 36Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ianalumab vs placebo in adults with Sjögren's disease and high symptom burden | Phase 3 | Peoria, Arizona and 71 other locations | Recruiting | Jun 2, 2026 |
| Ianalumab plus a thrombopoietin receptor agonist for adults with ITP or Evans syndrome | Phase 2 | Chandler, Arizona and 22 other locations | Recruiting | Feb 19, 2026 |
| Long-term follow-up of ianalumab with or without stopping treatment for people with lupus nephritis | Phase 3 | Orchard Park, New York and 52 other locations | Recruiting | Dec 2, 2024 |
| Long-term safety evaluation of ianalumab for systemic lupus erythematosus | Phase 3 | Anniston, Alabama and 166 other locations | Recruiting | Nov 18, 2023 |
All recruiting trials (4)
-
Ianalumab vs placebo in adults with Sjögren's disease and high symptom burden
A 52-week study will test whether monthly 300 mg ianalumab injections help adults with Sjögren's disease who have high symptom burden.
-
Ianalumab plus a thrombopoietin receptor agonist for adults with ITP or Evans syndrome
This study will test whether adding ianalumab to a doctor's chosen TPO-RA is tolerable for adults with immune thrombocytopenia (and an exploratory group with Evans syndrome) who have had prior treatments and are on a stable TPO-RA dose.
-
Long-term follow-up of ianalumab with or without stopping treatment for people with lupus nephritis
This 2-year extension will test whether continuing or stopping ianalumab keeps kidney disease under control and is safe for people with lupus nephritis who completed the core study.
-
Long-term safety evaluation of ianalumab for systemic lupus erythematosus
This study is testing the long-term safety of a medication called ianalumab in people with systemic lupus erythematosus who have already tried other treatments.
Quick answers
How many clinical trials of Ianalumab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 36 countries. The most sites are in United States (4 trials), Brazil (3 trials), China (3 trials), Colombia (3 trials), Czechia (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.